Table 1

Demographics and baseline characteristics stratified by leukoaraiosis severity

All patients (n=251)Absent to moderate LA (n=213)Severe LA (n=38)P values
Age, mean (SD),y64.4 (11.8)62.6 (11.3)74.6 (9.2)<0.001
Male, n (%)156 (62.2)140 (65.7)16 (42.1)0.006
Smoking, n (%)71 (28.3)64 (30.0)7 (18.4)0.143
Drinking, n (%)36 (14.3)32 (15.0)4 (10.5)0.466
LDL*, mean (SD), mmol/L2.57 (0.88)2.56 (0.89)2.60 (0.86)0.855
Glucose†, median (IQR), mmol/L6.80 (5.70–8.53)6.70 (5.59–8.30)7.89 (6.47–10.56)0.005
Medical history
 CHD, n (%)50 (19.9)35 (16.4)15 (39.5)0.001
 Atrial fibrillation, n (%)115 (45.8)92 (43.2)23 (60.5)0.048
 Hypertension, n (%)142 (56.6)112 (52.6)30 (78.9)0.003
 Diabetes mellitus, n (%)47 (18.7)35 (16.4)12 (31.6)0.027
 Ischemic stroke, n (%)32 (12.7)23 (10.8)9 (23.7)0.028
Clinical characteristics
 Baseline SBP, median (IQR), mm Hg140 (128–159)140 (127–155)149 (130–160)0.122
 Baseline NIHSS score, median (IQR)16 (12–20)15 (12–20)20 (15–25)<0.001
Stroke cause, n (%)0.930
 LAA98 (39)83 (39.0)15 (39.5)
 Cardioembolic129 (51.4)109 (51.2)20 (52.6)
 Undetermined or others24 (9.6)21 (9.9)3 (7.9)
Procedure process
 IVT, n (%)82 (32.7)77 (36.2)5 (13.2)0.005
 ASITN/SIR≥2, n (%)138 (55.0)123 (57.7)15 (39.5)0.037
 OTR, median (IQR), min361 (289–441)363 (294–442)356(278-442)0.486
 mTICI 2b/3, n (%)192 (76.5)163 (76.5)29 (76.3)0.978
  • ASITN/SIR indicates American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology; CHD, coronary heart diseases; IVT, intravenous thrombolysis; LA, leukoaraiosis; LAA, large-artery atherosclerosis; LDL, low-density lipoprotein; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institutes of Health Stroke Scale; OTR, symptoms onset to recanalization time; SBP, systolic blood pressure.

  • *Missing data in 63 patients.

  • †Missing data in 17 patients.